FBLG vs FULC

FibroBiologics, Inc. vs Fulcrum Therapeutics, Inc. — Valuation Comparison 2026

FBLG

Pharmaceutical Preparations
FibroBiologics, Inc.
Quality
4.1
out of 10
Value Trap
6
SAFE
Price
$1.16
Last close
Models
6/13
Active
VS

FULC

Pharmaceutical Preparations
Fulcrum Therapeutics, Inc.
Quality
6.5
out of 10
Value Trap
18
SAFE
Price
$6.92
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType FBLG Fair ValueFBLG Upside FULC Fair ValueFULC Upside
Bayesian DCF Intrinsic $0.22 -80.9% $2.10 -69.7%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.36 -94.5%
Dynamic NAV Asset-Based $1.70 +46.4% $3.71 -46.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for FBLG vs FULC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

FBLG vs FULC — Which Stock Is More Undervalued?

FULC scores higher with a 6.5/10 quality rating vs FBLG's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing FibroBiologics, Inc. (FBLG) and Fulcrum Therapeutics, Inc. (FULC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

FBLG currently trades at $1.16 with a QOC of 4.1/10, while FULC trades at $6.92 with a QOC of 6.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).